Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing

Patients with stage 1 Ménière's disease appear to have similar vertigo control with better hearing preservation than patients with advanced disease when treated with low-dose intratympanic gentamicin (10 mg/mL).